Member Info for madchick

Agree! It's all lookinggood since the placing. Once IO8 is up and running they shouldbe in great financial shape. Iodine prices help, if CBD comes off, we could be in a very good position. And this year the new iofina chemical product was supposed to be what will make this year exceptional. SP today doesn't matter as it all seems to be coming good and the SP will have to follow at some point. Although it has already done pretty well this year!

Interesting, regarding ZOE.

However, I'm not sure what ZOE would bring for IOF, given that currently IOF are not (yet) cash-rich. IOF has the upper hand on CBD and derivatives from that given that they have the chemicals expertise (let's hope there aren't any legal wrangles ahead!) and equipment to provide top quality products, and also now this tie-up in Belize, apparently.

It is interesting, though!

Eccles, I agree, although maybe the market needs to realize that FinnCap has increased their target price :-)

Jb, have you tried reading the RNSs from IOF? There's a lot of information in them. You can see them on the Iofina website, or investegate.co.uk (just search for IOF) or londonstockexchange - and even here, I believe, although I've never used this site for the RNS information.

Basically, we're waiting for new that IO8 will start being built - this should be soon but not necessarily in the next two months was what they said at the AGM in early June (so maybe mid August?). We're also waiting to hear more about the CBD opportunity; they should have the license by now, I believe, if they turned up to the orientation day, but we don't know how long their research period will last. They have the potential for partnering up on the CBD opportunity (presumably to scale more quickly), but I don't know when or if that will happen. Their derivatives side, IC, has a new product this year which it is ramping up on with production and should impact positively. With the recent placing, IOF should also be in a much better place financially now as well.

So, lots of good things to come, hopefully, but many of us have been here for many years and experienced a plethora of unfortunate events, so we all prefer to be cautious (we are a bit dependent on our oil partners for the brine for the iodine, for example; there could be problems in scaling up the CBD production for some reason, there could be a natural event causing damage to our best-producing plants, etc).

Also, you need to read carefully (particularly with RNSs). Like LO, I don't believe anyone on ADVFN said that production will start - that's something you (mis-)read into something that someone said; otherwise there'd have been a host of people correcting it. Most on ADVFN have been in this share a long time and so maybe don't spell things out that can seem misleading to new people; but misreading things can get people annoyed - just a friendly guidance.

I came online to pay my bills, so maybe I should do that :-(

ADVFN has been a nightmare over the last day or so, but it seems to be getting back to normal now - it is usually a good board.

In the RNS that I' reading it says
Adjusted EBITDA loss of £6.3m (2017: £1.5m profit), following a detailed accounting review

Forward looking statement
My boardroom colleagues and I are absolutely committed to restoring profitability as soon as possible, whilst recognising that it will take a little time for low margin contracts to expire.

Personal belief statement from Kalar
I believe the Group is well placed to achieve long term profitable growth underpinned by the people and systems we have in place."

Quiet isn't so bad! We should get some kind of update within the next month. Watched pot never boils ...

Good find!

Yes, they've truly turned the corner. Assessing new income streams sounds good and sounds like the next RNS will be on funding since that's their top priority. Finally, onwards and upwards from here, I hope!

How good to see the SP recovering but it's still pathetic - just hoping we can retain the rise and it won't dive once an RNS comes out. It must be time for the company to issue an RNS on we don't know why the sudden interest if they don't have anything to say soon (although half year results, which should be good, are due end of Sept).

Anyway, I'm not knocking it - just that it's well overdue, IMO!!

Boredom? Impatience?

We should be good by September if the funding's sorted and we can put out some good half-year results and outlook (should be good given iodine price is going up and IO.7 is pumping the iodine out).

Yes, I thought that was the most interesting part of the RNS; Iofina Chemical is really Tom's baby (and it's done really well - without that, IOF would probably have been sunk). I was a bit disappointed that the RNS didn't say much else that was new (nothing about IO.5, no update on how the financing is going, no update on current finances). However, good that we're on track and let's hope we achieve those end of year production rates! It's all going in the right direction, but there are still a few bits of news that we need to nail... hopefully this month?

Were you at the AGM? Since we didn't get an RNS today, I assumed they wouldn't really say anything they hadn't already said. Did they give any update on moving IO.5 or keeping it where it is, etc? Thank you for buying more - can't believe it's still drifting down - had hoped it would hold in the early 20s when it last rose!

I think we're all just waiting for Stena to finish selling. I wish they would start on IO.8 - even if they can't decide yet what to do with IO.5 (move or keep) and even if they hope that maybe someone else will fork out the costs for another plant if supplies get low, I don't think it would harm to get IO.8 going. Maybe they're waiting to sort out finances first? I guess if they're negotiating lower interest, then they'd avoid spending until then? That's the only thing I can think of!

Last year we had a production update and a trading update in April -- would be nice to get both again this year. I'd also like to know how the tests at relaying the brine to the other plants from Io.5 are going and whether they've finalised their plans for moving or keeping IO5 where it is. And also, which may be the same thing, what's going to happen about IO.8. It would also be nice to know if they've reached profitability... and, for the hell of it, why not just say something nice about Iofina chemical too :-) But, yes, sort of hoping for a production update this week.

Well, it's held up well after the placing and didn't drop below placing price which suggests actually that there's quite a bit of support. The CEO holds something like 65% of the shares. Also, they'll be trialing the water in June and then ramping that up in August/Sept. Also, it's pretty much guaranteed that this year will be better than last year, since they've already got orders in for this year that amount to last year's total, if I recall correctly. So, I'm not convinced this will drop and feel it could still go up - just a bit nervous with the PE ratio but that will fall as they gain sales (and I'm also not sure if I calculated correctly, but no-one's amended it for me!).

Well, evileye pointed out that they didn't really have the money for a dividend and AIM companies are usually on AIM so that they can raise funds at some point. At least YU. are raising funds when the SP is in a really healthy position (meaning less dilution than if they'd done it when the SP was back below 10 quid a share). It's usual for placings to follow after "pumping" the share since that's how they work to get the best price. I don't find it so shocking. Although I got out, I still believe in the YU. story - I think water will do well and I believe their claims that they will continue to do well over the next two years. Investment in expansion (re Dragons Den) is often necessary. It's debatable whether they should have offered a divi in these circumstances, but they do have very few shares in issue and most are owned by the CEO. So, his shareholding has been devalued, at least temporarily, as well.

After some deliberation, I also decided to sell - made a good profit here. I'd have liked to have seen the water business develop and theoretically they're bound to be beat 2017 in 2018, so from that point of view, plenty of room for optimism. However, it is a very high PER and I need to learn to protect my (rare) profits! I don't have anywhere else I want to put i just now, so I'll just hold on.

As indicated previously, a great set of results out today, with revenues for 2018 already known to be at least 50m (same as 2017) at the beginning of the year (so presumably more to come). Now they are shipping their own gas, that should also save on costs, I would imagine. I like the risk averse strategy (even though I'm a risk taker at heart!). I need to correct my last post - I see EPS is 17p which makes the PE ratio 70!! That's quite high, but the business is cooking on gas :-) There are few shares in circulation, so only a few buys or sells are likely to move the SP in either direction.

Yes, we should hear about IO.7 soon - would be nice if they could also report increasing iodine prices as well as increasing production moving forward. Not sure how long the field tests will take to see if they can divert brine from IO.5 to other plants and get an additional brine source or move IO.5. Wonder if they'll give an update at the same time as updating us on IO.7? Having said that, it's probably a bit soon for all that to have completed. I wonder if they'll update targets once they know that Io.7 is up and running and how it's doing. I hope they keep to the underpromise and overdeliver strategy, though. And, although no details, they keep on saying how well Iofina chemical is doing - easy to forget that. Not sure if seller will sell into any rise on IO.7 news and continue to curb the SP for a while? Still, the main thing is that Iofina is back on track and ready to run!

Thanks, it doesn't happen that often :-) They are now saying they'll beat forecasts in 2018 and 2019. They'll no doubt continue to expand the electricity business but the water opportunity should also be huge, which they aren't fully launching, it appears, until about August. Note the following (particularly last sentence) from the link I posted previously: Ofwat was expecting 30-40 applications for water supply and sewerage licences ahead of market opening. As it happened, there weren�t that many, and although the market operator MOSL and the regulator claim that there are 25 retailers in the market, the actual number of active companies is closer to 14 or 15. Meanwhile, MOSL figures show that 91,960 switch requests have been made since the market opened. This may sound like a lot, but it is important that we contextualise this number and remember that it is out of a possible 2.6 million SPIDs. As I see it, Yu Group have 50 million revenue and a market cap of just over 150 million. A very modest PE ratio of 6 should make the SP double what it currently is. There isn't a huge free float of shares. I'd really like to see a share split to lower the SP and make it seem more affordable, but that's just me.